Ranbaxy Laboratories Limited Share Price

Stocks

End-of-day quote NSE India S.E.
- ^INR	-

07/16/07	UCB : Pharma crusader takes India's drug regulators to court	RE
29/15/29	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE

07/16/07	UCB : Pharma crusader takes India's drug regulators to court	RE
29/15/29	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE
20/15/20	DAIICHI SANKYO : Japan's Daiichi Sankyo to sell up to $3.6 billion Sun Pharma stake	RE
31/15/31	DAIICHI SANKYO : Sun Pharmaceutical wins U.S. approval to buy Ranbaxy	RE
06/14/06	AstraZeneca : Ranbaxy prevail in Nexium antitrust trial	RE
20/14/20	AstraZeneca : U.S. court denies Ranbaxy's bid to block launch of rival generics	RE
18/14/18	AstraZeneca : Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies	RE
28/14/28	GlaxoSmithKline : Novartis results top forecasts as new products gain momentum	RE
31/14/31	AbbVie : AstraZeneca raises forecasts after seeing off Pfizer	RE
25/14/25	AbbVie : AstraZeneca results to get lift from bid foe Pfizer	RE
17/14/17	Novartis : Drugmaker Novartis to eke out more cost savings to lift margins	RE
24/14/24	Abbott India : Exclusive - India likely to extend price caps to more drugs: sources	RE
19/14/19	Mylan : EU to fine Servier, Teva for delaying generic drugs - sources	RE

04/15/04	Ranbaxy Laboratories : & APICON BREAK GUINNESS WORLD RECORD™	PU
28/15/28	Ranbaxy Laboratories : Q3FY 2015 Sales Rs.25,876Mn. YTD Dec’14 Sales Rs.81,778Mn	PU
06/14/06	Ranbaxy Laboratories : launches Red Heart Initiative to Raise Awareness on Women Heart Health	PU
01/14/01	Ranbaxy Laboratories : launches India’s first biosimilar of Infliximab drug, Infimab™	PU
29/14/29	Ranbaxy Laboratories : Q1 FY 2015 (Apr’14-Jun’14) Sales Rs.23.7 Bn	PU

17/14/17	Novartis : confirme l'objectif de croissance de ses ventes
17/14/17	Novartis : confirme l'objectif de croissance du C.A. annuel
19/14/19	Servier, Teva, d'autres à l'amende pour du "pay-for-delay"-sces
22/14/22	S& 500 : Vague de fusions dans le domaine de la pharmacie
07/14/07	Sun Pharmaceutical : Inde/Génériques-Sun Pharma acquiert Ranbaxy pour $3,2 mds

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+4.40%	+0.26%	+46.35%	+139.24%	1,20600Cr
JOHNSON & JOHNSON	+1.17%	+4.23%	+49.68%	+91.30%	66TCr
ABBVIE INC.	+0.70%	+1.43%	+33.95%	+112.24%	51TCr
ROCHE HOLDING AG	+2.77%	-0.57%	+49.44%	+68.42%	38TCr
MERCK & CO., INC.	+0.30%	+0.06%	+71.12%	+45.00%	36TCr
NOVARTIS AG	+0.29%	-0.24%	+30.84%	+57.23%	31TCr
ASTRAZENECA PLC	+0.98%	+0.76%	+9.04%	+38.31%	29TCr
AMGEN INC.	+1.01%	+0.01%	+43.82%	+76.28%	25TCr
GILEAD SCIENCES, INC.	+1.47%	-0.13%	+43.98%	+126.87%	21TCr
Average	+1.52%	-1.54%	+42.03%	+83.88%	46.44TCr
Weighted average by Cap.	+2.17%	-1.96%	+43.79%	+96.33%